Professional Documents
Culture Documents
Introduction To The Evidence Based Medicine: General Practice #1 Department
Introduction To The Evidence Based Medicine: General Practice #1 Department
ayatemir@gmail.com
ASTANA
2018
AIMS OF THE LECTURE
• Rules
• EBM definition.
• Evidence hierarchy in EBM;
• Description of basic research types in EBM;
• EMB steps
• SR and MA
Is it the right thing that we do?
• «My students are discouraged when I tell them that
half of what you are taught in 10 years will be
recognized as erroneous. The only problem is that no
one knows what it will be like»
S. Barwell
Harvard medicine Dean (1956)
Why we need it?
- easy access to medical information;
-increasing volume of scientific papers (annually more than 10000
articles publishing in the world, MEDLINE consist of more than 18,8
mln scientific papers);
- «knowledge survival»;
- «delay effect»
- lack of resources;
- subjective factor of information assessment
How we make clinical decisions nowadays?
First approach- experience,intuition, – «like professor said…»,
«written in the textbook…», «department chief order…»,
«pharmaceutical company advertisement».
«Some clinicians for 20 years make the same mistakes and call it a clinical
experience» Noya Fabricant, amer.phisician
How we make clinical decisions nowadays?
• Second approach -logic of scientific ideas (albumin at burn
shock, antihistamine at BA, distilben at pregnancy).
• Third approach– experimental data.
Our practice
1/3 interventions and treatment procedures has proven
effectiveness, and we provide them
1/3 interventions and treatment procedures has no proven
effectiveness, but we still keep to provide them
1/3 interventions and treatment procedures has proven
effectiveness, but we don’t use them in our clinical practice
Medical errors classification and
quality problems
1. Excessive using
2. Insufficient using
3. Misusing
4. Use with an unsettled result:
treatment or intervention, the results of
which are unknown
Evidences
There is no evidence that intravenous nitroglycerin,
commonly used in intensive care units during the acute
phase of myocardial infarction, can really affect the
prognosis of this disease
There is no difference in the effectiveness of different
NSAID groups
There is no evidence that ARBs are more effective than
ACE inhibitors in preventing vascular complications
There is no evidence of the effectiveness of antiviral
drugs Arbidol, Tamiflu, Relenza in the prevention and
treatment of influenza
There is no evidence of efficacy of nootropics in the
prevention of mortality from vascular events
There is no evidence of the effectiveness of
hepatoprotectors in prolonging life expectancy in the
treatment of liver diseases
There is no evidence of efficacy of dipyridamole, trental
in the treatment of diabetic microangiopathy
There is no evidence of the effectiveness of Echinacea as
an immunomodulatory
In the western pharmaceutical reference
books there are no groups of following drugs
Hepatoprotectors
Angioprotectors
Cholagogue
Nootropics
Рассасывающие
Imuunomodulators
Examples of non-existent in the world diagnoses and
"diseases".
Neurocirculatory dystonia
Hypertensive syndrome at children (intracranial hypertension)
Intestine dysbacteriosis
Chronic bronchitis with asthmatic component
Chronic enterocolitis
Frequently and unreasonably
presented diagnoses:
Chronic cholecystitis (95% - calculous).
Chronic pyelonephritis (without
bacterial culture of urine, using
outdated tests, based only on kidney US).
Others
Ignored or no sufficient diagnostic of very
common diseases